1. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
   Rogerio M Castilho et al, 2017, Int J Mol Sci CrossRef
2. Structure-based design and biological characterization of selective histone deacetylase 8 (HDAC8) inhibitors with anti-neuroblastoma activity
   Tino Heimburg et al, 2017, J. Med. Chem. CrossRef
3. Cellular Plasticity–Targeted Therapy in Head and Neck Cancers
   W. Shang et al, 2018, J Dent Res CrossRef
4. Structure-activity relationships of HDAC8 inhibitors: Non-hydroxamates as anticancer agents
   Sk. Abdul Amin et al, 2018, Pharmacological Research CrossRef
5. Selective and nonselective HDAC8 inhibitors: a therapeutic patent review
   Nilanjan Adhikari et al, 2019, Pharmaceutical Patent Analyst CrossRef
6. Thymoquinone-Induced Reactivation of Tumor Suppressor Genes in Cancer Cells Involves Epigenetic Mechanisms
   Shahad A Qadi et al, 2019, Genet Epigenet CrossRef
7. Epigenetic Modifications of Autophagy in Cancer and Cancer Therapeutics
   Chandra S. Bhol et al, 2019, Seminars in Cancer Biology CrossRef
8. Histone modifications in oral squamous cell carcinoma and oral potentially malignant disorders
   Huamei Yang et al, 2019, Oral Dis CrossRef
9. Development of decision trees to discriminate HDAC8 inhibitors and non-inhibitors using recursive partitioning
   Sk. Abdul Amin et al, 2019, Journal of Biomolecular Structure and Dynamics CrossRef
10. Induction of Apoptosis and Autophagy in Breast Cancer Cells by a Novel HDAC8 Inhibitor
    Chang-Fang Chiu et al, 2019, Biomolecules CrossRef
11. Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes
    Paul Peixoto et al, 2019, Cells CrossRef
12. Essential elements regulating HDAC8 inhibition: a classification based structural analysis and enzyme-inhibitor interaction study of hydroxamate based HDAC8 inhibitors
    Suvankar Banerjee et al, 2019, Journal of Biomolecular Structure and Dynamics CrossRef
13. C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC.
    Xiyan Chen et al, 0 CrossRef
14. Chidamide induces necroptosis via regulation of c‑FLIPL expression in Jurkat and HUT‑78 cells
    Zuofei Chi et al, 2019, Mol Med Report CrossRef
15. HDAC inhibitor apicidin suppresses murine oral squamous cell carcinoma cell growth in�vitro and in�vivo via inhibiting HDAC8 expression
    Mee‑Young Ahn, 2018, Oncol Lett CrossRef
16. Histone deacetylase 1 regulates the malignancy of oral cancer cells via miR-154-5p/PCNA axis
    Yuanjing Lv et al, 2020 CrossRef
17. Strong Involvement of Classical Histone Deacetylases and Mechanistically Distinct Sirtuins in Bellicose Cancers
    Shabir Ahmad Ganai, 2020 CrossRef
18. Epigenetic regulation of autophagy: A key modification in cancer cells and cancer stem cells
    Harpreet K Mandhair et al, 2021, WJSC CrossRef
19. Expression and prognostic analyses of HDACs in human gastric cancer based on bioinformatic analysis
    Luting Chen et al, 2021 CrossRef
20. Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia
    Dimitrios Goutas et al, 2021, Diagnostics CrossRef
21. Identification of unique subtype-specific interaction features in Class II zinc-dependent HDAC subtype binding pockets: A computational study
    Shweta Ukey et al, 2021, J Biosci CrossRef
22. Targeting Autophagy-Related Epigenetic Regulators for Cancer Drug Discovery
    Yang Li et al, 2021, J. Med. Chem. CrossRef
23. In-Silico Analysis of Chromatin Modifiers and Profiling of Histone Deacetylases (HDAC's) in Human Oral Cancer
    Anand K. Sajnani et al, 2021, Chonnam Med J CrossRef
24. Circ_0039411 promotes papillary thyroid carcinoma development through mediating the miR-423-5p/SOX4 signaling
    Xiaohui Wen et al, 2021, Int J Biol Markers CrossRef
25. Cinobufagin Exerts Anticancer Activity in Oral Squamous Cell Carcinoma Cells through Downregulation of ANO1
    Sungwoo Jo et al, 2021, IJMS CrossRef
26. Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma
    Pavel Hurník et al, 2022, Front. Genet. CrossRef
27. Epigenetic dysregulation in autophagy signaling as a driver of viral manifested oral carcinogenesis
    Srimanta Patra et al, 2022, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
28. circRNA mannosidase alpha class 1A member 2 contributes to the proliferation and motility of papillary thyroid cancer cells through upregulating metadherin via absorbing microRNA-449a
    Yao Feng et al, 2022 CrossRef
29. Pathological Role of HDAC8: Cancer and Beyond
    Ji Yoon Kim et al, 2022, Cells CrossRef
30. Downregulation of histone deacetylase 8 (HDAC8) alleviated the progression of oral submucous fibrosis
    Hui-Wen Yang et al, 2022, Journal of Dental Sciences CrossRef
31. A comparative quantitative structural assessment of benzothiazine-derived HDAC8 inhibitors by predictive ligand-based drug designing approaches
    S. Banerjee et al, 2022, SAR and QSAR in Environmental Research CrossRef
32. NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma
    Rahul Arora et al, 2023, Cancer Gene Ther CrossRef
33. HDAC8 Deacetylates HIF-1α and Enhances Its Protein Stability to Promote Tumor Growth and Migration in Melanoma
    Ji Yoon Kim et al, 2023, Cancers CrossRef
34. The role of acetylation of histone H3 and H4 in oral squamous cell carcinoma
    Lian Li et al, 2023 CrossRef
35. Molecular mechanisms in regulation of autophagy and apoptosis in view of epigenetic regulation of genes and involvement of liquid-liquid phase separation
    Subhajit Chakraborty et al, 2024, Cancer Letters CrossRef
36. Therapeutic Strategies in Oral Cancer - A Review
    Sangeetha. R et al, 2024, RJPT CrossRef
37. Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets
    Mengchen Xu et al, 2024, J Transl Med CrossRef
38. Epigenetic regulation of head and neck cancer by microRNAs
    Dimple Patel et al, 2024 CrossRef
39. A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013-present)
    Suvankar Banerjee et al, 2024, Expert Opinion on Therapeutic Patents CrossRef
40. In silico identification of dual HDAC8 and MMP9 inhibitors by pharmacophore modeling, molecular docking, and molecular dynamics simulation studies for development of antitumour agent
    Kakali Sarkar et al, 2024, Interactions CrossRef
41. Repurposing of DrugBank molecules as dual non-hydroxamate HDAC8 and HDAC2 inhibitors by pharmacophore modeling, molecular docking, and molecular dynamics studies
    Kakali Sarkar et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef